← back to search

Ye Wei

University of Southern California · US
Area of research
Oncology · Hepatology
Research interest
Research interests include Colorectal Cancer Surgical Treatments, Hepatocellular Carcinoma Treatment and Prognosis, Colorectal Cancer Treatments and Studies, and Cancer, Lipids, and Metabolism.
h-index
44
citations
7,039
works
363
NIH funding
primary concept
email

Recent publications

Robotic vs Laparoscopic Surgery for Middle and Low Rectal Cancer
JAMA 2025cited by 73position: middledoi
Global research trends of peripheral nerve surgery: a bibliometric and visualized analysis
Neurosurgical Review 2025cited by 3position: middledoi
Niclosamide prodrug enhances oral bioavailability and efficacy against hepatocellular carcinoma by targeting vasorin‐TGFβ signalling
British Journal of Pharmacology 2025cited by 2position: middledoi
Influence of surgical start time on the quality of surgery for middle and low rectal cancer: a post hoc analysis of the real trial
International Journal of Surgery 2025cited by 2position: middledoi
Chemoradiotherapy (CRT) followed by sequential tislelizumab (TIS) + CAPOX and TIS monotherapy for organ preservation in locally advanced low rectal cancer.
Journal of Clinical Oncology 2025cited by 0position: middledoi
741P Chemoradiotherapy (CRT) followed by sequential tislelizumab (TIS) + CAPOX and TIS for organ preservation in low rectal cancer (RELIEVE-01): Primary results
Annals of Oncology 2025cited by 0position: middledoi
Laparoscopy-assisted versus open surgery for low rectal cancer (LASRE): 3-year survival outcomes of a multicentre, randomised, controlled, non-inferiority trial
˜The œLancet. Gastroenterology & hepatology 2024cited by 22position: middledoi
A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
Clinical Cancer Research 2024cited by 10position: middledoi
Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): Primary outcome of a multicenter randomized controlled trial.
Journal of Clinical Oncology 2024cited by 6position: middledoi
EGFR and MUC1 as dual-TAA drug targets for lung cancer and colorectal cancer
Frontiers in Oncology 2024cited by 6position: middledoi
The “Hand-as-Foot” teaching method in ventriculoperitoneal shunt
Asian Journal of Surgery 2024cited by 1position: middledoi
Robotic versus open surgery for simultaneous resection of rectal cancer and liver metastases: a randomized controlled trial
International Journal of Surgery 2023cited by 37position: middledoi
Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomas
Lung Cancer 2023cited by 19position: middledoi
International guideline on natural orifice specimen extraction surgery (NOSES) for colorectal cancer (2023 version)
Holistic Integrative Oncology 2023cited by 12position: middledoi
Prevalence and risk factors for minimal hepatic encephalopathy in cirrhotic patients with different etiologies
Portal hypertension & cirrhosis 2023cited by 3position: middledoi
International Guideline on Natural Orifice Specimen Extraction Surgery (NOSES) for Colorectal Cancer (2023 Version)
2023cited by 1position: middledoi
IDDF2023-ABS-0075 A prospective, multicenter study of minimal hepatic encephalopathy prevalence and relationship with quality of life in patients with cirrhosis in china
2023cited by 0position: middledoi
Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial
˜The œLancet. Gastroenterology & hepatology 2022cited by 445position: middledoi
Short-term Outcomes of Laparoscopy-Assisted vs Open Surgery for Patients With Low Rectal Cancer
JAMA Oncology 2022cited by 94position: middledoi
Robotic versus laparoscopic abdominoperineal resections for low rectal cancer: A single‐center randomized controlled trial
Journal of Surgical Oncology 2022cited by 53position: middledoi
Short-term and oncological outcomes of natural orifice specimen extraction surgery (NOSES) for colorectal cancer in China: a national database study of 5055 patients
Science Bulletin 2022cited by 41position: middledoi
Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): Short-term outcomes of a multicenter randomized controlled trial.
Journal of Clinical Oncology 2022cited by 9position: middledoi
Bevacizumab Plus mFOLFOX6 Versus mFOLFOX6 Alone as First-Line Treatment for <i>RAS</i> Mutant Unresectable Colorectal Liver-Limited Metastases: The BECOME Randomized Controlled Trial
Journal of Clinical Oncology 2020cited by 117position: middledoi
A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases
Journal of Translational Medicine 2020cited by 85position: middledoi
Comprehensive Evaluation of Relapse Risk (CERR) Score for Colorectal Liver Metastases: Development and Validation
The Oncologist 2020cited by 45position: middledoi
Robotic colorectal cancer surgery in China: a nationwide retrospective observational study
Surgical Endoscopy 2020cited by 22position: middledoi
International consensus on natural orifice specimen extraction surgery (NOSES) for colorectal cancer
Gastroenterology report 2019cited by 171position: middledoi
Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer
Clinical Cancer Research 2019cited by 162position: middledoi
The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1–STAT3 signaling pathway
Cell Death and Disease 2019cited by 71position: middledoi
Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer
Cancer Management and Research 2018cited by 145position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jianmin Xu · Arkansas State University20 papers (2013–2025)Li Ren · Ministry of Industry and Information Technology13 papers (2012–2023)Guodong He · Sun Yat-sen University13 papers (2016–2025)Dexiang Zhu · Sun Yat-sen University11 papers (2013–2022)Wentao Tang · Chongqing University8 papers (2016–2025)Wenju Chang · Fuzhou University8 papers (2016–2024)Qingyang Feng · Sun Yat-sen University8 papers (2016–2025)Fei Liang · American Petroleum Institute8 papers (2020–2025)Baoqing Jia · Chinese PLA General Hospital6 papers (2022–2025)Lechi Ye · Sun Yat-sen University6 papers (2012–2016)Qi Lin · Central South University6 papers (2014–2020)Jianmin Xu · Sun Yat-sen University5 papers (2012–2024)Meiling Ji · Zhongshan Hospital5 papers (2016–2020)Xiaoqiao Zhang · Hubei University of Medicine5 papers (2022–2025)Weitang Yuan · First Affiliated Hospital of Zhengzhou University5 papers (2022–2025)Qing‐Hai Ye · Sun Yat-sen University5 papers (2012–2023) · 5 papers (2022–2025)Taiyuan Li · Nanchang University5 papers (2022–2025)Wei Zhang · Nanchang Hangkong University5 papers (2022–2025)Jia Fan · China Medical University4 papers (2012–2024)